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Abstract 
Background: Methicillin-resistant Staphylococcus aureus (MRSA) which causes nosocomial 
infections is among the most important multi-resistant pathogens worldwide. Investigations of 
MRSA outbreaks in nosocomial settings often require strain-typing data to verify effectively that 
the isolates belong to the outbreak strain, and to discriminate similarity from unsimilarity strains. 
Quick and reliable typing methods are required to obtain information among MRSA isolates and to 
allow faster implementation of appropriate control measures. 
Objective : The aim of this study was to investigate genotyping of methicillin resistant and 
sensitive Staphylococcus aureus (MRSA and MSSA) in Khartoum Teaching Hospital, Sudan by 
using antibiotype and polymerase chain reaction-restriction fragment length polymorphism (PCR-
RFLP) of the coagulase gene. 
Methods: This is across sectional study. The samples were collected from clinical wound 
specimens in the wards of surgery, orthopaedic and burns at Khartoum Teaching Hospital, then 
processed, cultured and subsequently susceptibility test was performed using disc diffusion method. 
The MRSA strains were investigated by oxacillin 1µg disk diffusion method. PCR used to amplify 
a sequence of the coagulase (coa) gene, and the PCR products were analyzed by PCR-RFLP using 
Alu1 restriction enzyme. 
Result: Forty eight S. aureus strains were isolated and the number of MRSA identified was 
9(18.75%). All strains of MRSA and MSSA were sensitive to vancomycin, while multi-drug 
resistance was common among MRSA strains. PCR amplification products of coa gene were 
approximately at 500 bp (26/48), and 580 bp (22/48). By Alu1 restriction enzyme digestion of the 
PCR-amplified of coagulase gene, two distinct PCR-RFLP patterns exhibited; coaA and coaB and 
their fragments were approximately at 190, 310 bp and 190, 390 bp with percentages of 54.2% 
(26/48) and 45.8% (22/48) respectively. 
Conclusion: PCR-RFLP is considered an attractive tool for rapidly demonstrate the frequency of 
different patterns and discriminate the relatedness of isolates in different hospital wards. 
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fragment length polymorphism (RFLP) 
 
taphylococcus aureus has long been 
recognized as being an important 
pathogen in human disease. Serious 
staphylococcal infections can frequently 
occur in patients and may lead to dire 
consequences, especially for therapy with 
antimicrobial agents 1. Outbreaks of hospital 
acquired infections due to methicillin resistant 
S. aureus (MRSA) are being reported with 
increasing frequency, challenging clinicians 
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and infection control teams throughout the 
world2.
Phenotypic markers can be used to identify 
MRSA. The antibiogram has been the main 
typing tool in many hospital outbreaks since 
the technique is widely available and 
standardized, and it can be used with all 
microbial species 3.
Coagulase production is the principal 
criterion used by the clinical microbiology 
laboratory for the identification of S. aureus 
isolates from human infections 4. Besides the 
traditional typing methods for MRSA, several 
alternative molecular techniques have been 
developed for epidemiological studies. 
S
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Among these are pulsed-field gel 
electrophoresis (PFGE)3, polymerase chain 
reaction (PCR) of the coagulase (coa) gene, 
the protein A (spa) gene, hypervariable 
regions (HVR) adjacent to the mecA gene 5,6. 
DNA sequencing and polymerase chain 
reaction restriction fragment length 
polymorphism (PCR-RFLP) of the coa and 
spa genes 7. The PCR amplifications of these 
particular regions produce DNA fragments of 
different sizes and are highly polymorphic 
with regard to the number and sequence of the 
repeats 8.
Investigation of staphylococcal isolates 
(MRSA and MSSA) outbreak in nosocomial 
settings often requires strain-typing data to 
verify effectively that the isolates belong to 
the outbreak and discriminate similarity from 
unsimilarity strains. Therefore, the aim of this 
study was to investigate the epidemiological 
typing of S. aureus isolates from Khartoum 
Teaching Hospital by using polymerase chain 
reaction-restriction fragment length 
polymorphism (PCR-RFLP) of the coagulase 
(coa) gene. 
Materials and Methods 
 The samples were collected from clinical 
wound specimens in the wards of surgery, 
orthopaedic and burns at Khartoum Teaching 
Hospital, Sudan in the period September 2005 
to August 2007. S. aureus ATCC 43300, 
coagulase negative staphylococci (S.
epidermidis), were included as positive and 
negative controls for PCR testing of the coa 
gene polymorphism.  
 All isolates were identified by standard 
microbiological methods including Gram 
stain, catalase, coagulase, DNase and growth 
on mannitol salt agar. Resistant to oxacillin 
was determined by the disc diffusion method 
according to the National Committee for 
Clinical Laboratory Standard (NCCLS) 
guidelines.  
 Antimicrobial susceptibility testing was 
performed by the disc diffusion method on 
Mueller-Hinton agar (Oxoid), to tested 10 
antimicrobial agents: cephalexine Cp (30 
mcg), co-trimoxazole Co (25 mcg), 
clindamycin Cd (2 mcg), erythromycin E (15 
mcg), vancomycin Va (30 mcg), tetracycline 
T (30 mcg), rifampicin R (5 mcg), amoxicillin 
Am (10 mcg), and ciprofloxacin Cf (5 µg). A 
suspension of the tested organisms was 
adjusted against 0.5 MacFarland standard 
turbidity and inoculated onto media, then 
incubated at 35-37 °C for 16-18 hours, and 
examined for evidence of growth. 
 Stock clinical cultures were maintained in 
brain heart infusion broth-glycerol mixture 
(3:1 vol/vol) at –70ºC until further molecular 
analysis 2.
Genomic DNA was isolated by using 
chloroform DNA purification protocol. With 
a 1µl loop, a small quantity of growth 
equivalent to about two small colonies was 
scraped from the top of the culture and placed 
into 100µl of sterile distilled water in a 
microcentrifuge tube. Chloroform 100µl 
(Sigma) was added, and the mixture was 
vortexed for about 10 seconds. The mixture 
was heated at 80°C for 20 minutes, after 
which time it was held at -20°C for at least 20 
minutes. The sample was allowed to thaw but 
while still cold was centrifuged at 12,000xg 
for 3 minutes in a minicentrifuge. The DNA 
was stored at -20°C and ready for use9.
The coa gene was amplified with two 
primers, as described by 8. The forward 
primer 5′-ATA GAG ATG CTG GTA CAG 
G-3′ (1513 to 1531) and the reverse primer 5′-
GCT TCC GAT TGT TCG ATG C-3′ (2188 
to 2168) were chosen. The PCR reaction 
mixture contained of reaction buffer (5µl), 
500U Go Taq DNA polymerase (0.5µl) 
(Promega), 10mM dNTPs mix (1µl), 25mM 
MgCl2 (3µl), 10PM forward primer (12µl), 
10PM reverse primer (8.8µl), template DNA 
(5µl), and distilled water (14.7µl) to a final 
volume 50µl. DNA amplifications were 
performed in thermal cycles as the following 
cycling parameters: an initial step at 94°C for 
3 minutes; 30 cycles of 94°C for 1 minute, 
55°C for 1 minute, and 72°C for 1 minute; 
and a final step at 72°C for 4 minutes. The 
PCR-amplified samples were subjected to 
electrophoresis on 0.8% agarose gel with 
ethidium bromide incorporated for DNA 
staining. The PCR products were visualized 
and photographed on an UV transilluminator, 
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and the sizes of the PCR products were 
determined by comparison to 100-1000 ladder 
DNA marker (Sigma). 
 After amplification, ten microliters of PCR 
product was mixed and digested with 2 units 
(0.2µl) of restriction endonuclease AluI
(Promega) at 37°C for 1 hr 30 minutes. The 
restriction digested fragments were 
electrophoresis on 1% agarose gel, which 
were visualized under UV light. Photographs 
of agarose gel were taken using gel 
documentation system, and the pictures were 
further analyzed with computer and printed. 
Results 
Forty eight S. aureus isolates were 
collected and the number of MRSA identified 
was 9(18.75%). All isolates were classified 
into 3 groups; group І: S. aureus isolated from 
surgical ward (No. = 28; 58.3%), group ІІ: S. 
aureus isolated from orthopaedic ward (No. = 
14; 29.2%), and group ІІІ: S. aureus isolated 
from burns unit (No. = 6; 12.5%). 
 The susceptibility test was conducted for 
48 S. aureus isolates against 10 antimicrobial 
agents by disc diffusion method. All isolates 
showed 100% sensitivity to vancomycin. For 
the other antibiotics, the degree of sensitivity 
was; co-trimoxazole 27 (56.25%), rifampicin 
35 (72.9%), clindamycin 33 (68.75%), 
tetracycline 16 (33.3%), erythromycin 31 
(64.6%), cephalexine 29 (60.4%), methicillin 
39 (81.25%), amoxicillin 19 (39.6%), and 
ciprofloxacin 32 (66.7%). 
 All 48 S. aureus isolates examined 
produced PCR amplicon when coagulase 
gene primers were used. The two PCR size 
products obtained were approximately at 500 
bp (26 isolates), and 580 bp (22 isolates). An 
isolate of CoNS (S. epidermidis) and 
Escherichia coli which served as negative 
controls produced no DNA product following 
PCR amplification (Fig. 1). 
PCR products from coagulase gene specific 
primers were digested with AluI restriction 
enzyme, and the resulting fragments were 
separated by gel electrophoresis. Two distinct 
patterns were detected among S. aureus 
isolates; coaA and coaB with sizes 
approximately at 190, 310 bp and 190, 390 
bp. The percentages of these patterns were 
54.2% and 45.8% respectively (Fig. 2).  
 
M 1 2 3 4 5 6 7
Figure 1: 0.8% agarose gel electrophoresis of PCR 
amplification of the coagulase gene products from the 
S. aureus isolates. Lane M (100 bp ladder) DNA 
marker. Lanes 1, 2, 4 580 bp fragment. Lanes 3, 5, 6 
500 bp fragment. Lane 7 no DNA (CoNS) S. 
epidermidis product. 
 M 1 2 3 4 5 6 7
Figure 2: 1% agarose gel electrophoresis of AluІ
restriction enzyme digestion products of the coagulase 
gene PCR products. Lane M (100 bp ladder) DNA 
marker. Lanes 1-3 pattern coaA (190 and 310 bp). 
Lanes 4-6 pattern coaB (190 and 390 bp).  
 
The frequency of different patterns in 
different hospital wards as following; group І
surgical ward: the prevalence of pattern A 






Eidha A. Bin Hameed                                                                      Molecular Genotyping of M R SA  
© Sudan JMS Vol. 5, o. 2, June 2010            114
of 28 (46.4 %), group ІІ orthopaedic ward: the 
prevalence of pattern A was 9 of 14 (64.3 %) 
and pattern B was 5 of 14 (35.7 %), group ІІІ 
burns unit: the prevalence of pattern A was 2 
of 6 (33.3 %) and pattern B was 4 of 6 (66.7 
%) (Table 1). 
 
Table 1: Frequency of S. aureus /PCR-RFLP in each hospital wards 
coa 
patterns 











No. (%) No. (%) No. (%) No. (%) 
A 190-310 26 (54.2) 15 (53.6) 9 (64.3) 2 (33.3) 
B 190-390 22 (45.8) 13 (46.4) 5 (35.7) 4 (66.7) 
Total 48 (100) 28 (100) 14 (100) 6 (100) 
Discussion 
 The objective of this study was to 
determine whether PCR-RFLP of the 
coagulase gene could be used to differentiate 
the similarity or unsimilarity between the 
tested isolates. The coagulase gene from 48 
isolates was amplified by PCR, and the 
products were digested with endonuclease 
enzyme AluI. Therefore, PCR-RFLP analysis 
showed that two different restriction profile 
patterns coaA, and coaB, could be identified 
according to their PCR end products at 190, 
310 bp and 190, 390 bp respectively. The use 
of DNA restriction endonuclease to digest the 
coagulase gene was beneficial in confirming 
the two distinct RFLP patterns among S.
aureus strains. In addition, PCR-RFLP 
pattern analysis allowed the differentiation of 
isolates (Fig. 2). The prevalence of different 
patterns in different hospital wards could be 
demonstrated, as well as the similarity or 
unsimilarity between the tested isolates.  
 Coagulase is produced by all strains of S.
aureus, its production is the principal 
criterion used in the clinical microbiology 
laboratory for the identification of S. aureus 
in human infections, and it is thought to be an 
important virulence factor 10. The coa gene 
coding for the coagulase protein has been 
considered a candidate for the development of 
DNA-based diagnostic assays for S. aureus.
We presented evidence of existence type of  
coagulase gene among 48 S. aureus strains 
 
examined by PCR, and the products generated 
size variations in the amplicon primer. We 
found two size products obtained  
approximately at 500 bp and 580 bp of PCR-
coagulase gene, because this gene is highly 
polymorphic. 
Numerous allelic forms of S. aureus 
coagulase exist, with each isolate producing 
one or more of these enzyme variants. By 
digestion with AluI restriction enzyme of the 
amplified gene product, it is possible to 
discriminate between S. aureus isolates by 
RFLP of the coagulase gene 4. Therefore, the 
main purpose of present study was to 
establish a rapid and reliable molecular typing 
method for S. aureus by means of PCR-RFLP 
of coagulase gene, and this was accomplished 
within a single PCR-coagulase gene 
following amplimer digestion with AluI that 
resulted in reproducible restriction patterns 
and allowed sufficient discrimination among 
strains isolated from Khartoum Teaching 
Hospital. 
For RFLP coagulase gene typing, two distinct 
patterns were detected, and the number of 
fragments produced upon AluI digestion were 
two bands. These results differ from previous 
studies in which AluI PCR-RFLP fragments 
varied from one to four bands using the same 
primer sequences 8, 10. However, other studies  
with different primer sequence of coa gene 
showed AluI PCR-RFLP fragments varied 
from two to three bands 4, 11.
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In this study we found that the coaA pattern 
was common in multiple antibiotic resistance 
strains MRSA and MSSA, and the DNA 
sequence differences in the staphylocoagulase 
gene are responsible for the polymorphic 
restriction fragment length patterns seen 
among the S. aureus isolates. The reason for 
this polymorphism in the coagulase gene 
among S. aureus strains is unclear, but the 
extensive polymorphism observed does 
suggest that the coagulase gene may be an 
important virulence determinant for this 
organism 4.
The coagulase gene RFLP method for 
typing of S. aureus isolates is far simpler than 
those previously reported. It requires only 
small quantities of crude DNA, and individual 
strains can be compared easily by both the 
number of PCR-amplified gene products and 
the sizes of their AluI restriction enzyme 
digest fragments. However, the coagulase 
gene typing has been reported to be a new 
attractive method for clinical laboratories 
because of its ease and speed4.
Conclusion 
Restriction analysis by PCR-RFLP 
permitted discrimination of the tested strains 
by exhibiting specific PCR-RFLP patterns, 
and we could rapidly demonstrate the 
prevalence of different patterns in different 
hospital wards between the tested isolates. 
Therefore, PCR-RFLP represents a powerful, 
rapid and reliable molecular typing system as 
well as an alternative tool for routine 
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